Thermo Fisher Scientific has announced the launch of Thermo Scientific™ Brilliance™ Candida 2 Agar and Spectra™ Candida Agar, new colour-based (chromogenic) culture media to help laboratories quickly detect and differentiate clinically important Candida species, including Candida auris, a growing global antimicrobial resistance (AMR) threat.
Invasive fungal infections are an increasing challenge for healthcare systems worldwide, driven in part by the rapid spread of Candida auris. This pathogen is often resistant to multiple antifungal treatments, can spread quickly in healthcare settings and is associated with serious illness and high mortality rates.
As screening and surveillance efforts expand, clinical microbiology laboratories need faster, reliable tools to identify infections and support infection prevention and control.
Thermo Scientific Brilliance Candida 2 Agar and Spectra Candida Agar are designed to address this need by enabling clear, species-specific chromogenic reactions directly from primary culture. This allows laboratories to visually differentiate the most clinically relevant Candida species, including direct identification of Candida auris, with shorter incubation times compared to conventional culture methods. Earlier intervention can support timely clinical decisions, appropriate antifungal therapy, and rapid infection control measures during routine screening and outbreak investigations.
